Adeza to Hold 2005 Fourth Quarter and Year End Financial Results Conference Call on March 2
23 Febrero 2006 - 4:24PM
Business Wire
Adeza (NASDAQ:ADZA) today announced it will release financial
results for the quarter and year ended December 31, 2005 after
market close on Thursday, March 2, 2006. Adeza's management will
host an investment-community conference call at 4:30 p.m. Eastern
Time (1:30 p.m. Pacific Time) to discuss those results, introduce
2006 full-year financial guidance and answer questions. Individuals
interested in participating in the conference call may do so by
dialing (888) 463-4383 for domestic callers, or (706) 634-5615 for
international callers. Those interested in listening to the
conference call live via the Internet may do so by visiting the
Investors section of the company's Web site at www.adeza.com. A
telephone replay will be available for 48 hours following the
conclusion of the call by dialing (800) 642-1687 for domestic
callers, or (706) 645-9291 for international callers, and entering
reservation code 5350834. A webcast replay will be available by
visiting the Investors section on the Adeza Web site. About Adeza
Adeza designs, manufactures and markets innovative products for
women's health. Adeza's initial focus is on reproductive
healthcare, using its proprietary technologies to predict preterm
birth and assess infertility. Adeza's principal product is a
patented diagnostic test, FullTerm(TM), The Fetal Fibronectin Test,
which utilizes a single-use, disposable cassette and is analyzed on
Adeza's patented TLiIQ(R) System. This product is approved by the
U.S. Food and Drug Administration (FDA) for use in assessing the
risk of preterm birth. Adeza also markets and sells the
E-tegrity(R) Test, an infertility-related test to assess
receptivity of the uterus to embryo implantation in women with
unexplained infertility. More information is available at
www.adeza.com. Adeza cautions you that statements included in this
press release that are not a description of historical facts may be
forward-looking statements. The inclusion of forward-looking
statements should not be regarded as a representation by Adeza that
any of its plans will be achieved. Actual results may differ
materially from those set forth in this release due to the risks
and uncertainties inherent in Adeza's business including, without
limitation, statements about the expansion of the indications for
its products. All forward-looking statements are qualified in their
entirety by this cautionary statement and Adeza undertakes no
obligation to revise or update this news release to reflect events
or circumstances after the date hereof.
Adeza (NASDAQ:ADZA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Adeza (NASDAQ:ADZA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Adeza Biomedical (MM) (NASDAQ): 0 recent articles
Más de Adeza Artículos de Noticias